Acebrophylline Sustained Release Tablets 200 mg – PHILBRO 200 SR

Acebrophylline Sustained Release Tablets 200 mg  – Full day action against obstructive respiratory conditions.

PHILBRO 200 SR – Acebrophylline 200 mg sustained release tablet is a xanthine derivative that combines bronchodilator and mucoregulator properties. It works by relaxing the smooth muscles of the airways (via phosphodiesterase inhibition) and controlling inflammation by modulating cytokine activity. This makes it effective in managing chronic obstructive pulmonary disease (COPD), asthma, and other obstructive airway diseases.

Recommended by Specialists:
✅Pulmonologists – For treating chronic respiratory conditions such as asthma and COPD.
✅General Physicians – For managing acute and chronic respiratory conditions.

Key Benefits of Acebrophylline Sustained Release Tablets 200 mg – PHILBRO 200 SR:
✅Sustained Release Formula: Ensures prolonged bronchodilation and anti-inflammatory action for 24-hour respiratory relief.
✅Dual Benefit: Acts as a bronchodilator and mucoregulator, effectively managing airway obstruction and mucus overproduction.
✅Enhanced Tolerability: Minimizes gastrointestinal side effects associated with xanthines, ensuring better patient compliance.

Indications:
✅Chronic Obstructive Pulmonary Disease (COPD)
✅Bronchial Asthma
✅Chronic Bronchitis